OHSU, University of Washington scientists partner to form regional center aimed at combating infectious diseases
On Apr. 15, 2009, Oregon Health & Science University (OHSU) and the University of Washington (UW), along with…
On Apr. 15, 2009, Oregon Health & Science University (OHSU) and the University of Washington (UW), along with…
On Feb. 25, 2008, Oregon State University’s James Carrington, a professor of botany and plant pathology and a…
On Jan. 21, 2009, the Knight Cancer Institute announced the recruitment of lung oncology expert Alan Sandler, M.D.,…
On Jan. 20, 2009, the Knight Cancer Institute announced the recruitment of surgeon Chris Amling, M.D., chief of…
On Oct. 29, 2008, Oregon Health & Science University (OHSU) announced that Nike founder Philip H. Knight and…
On Jun. 27, 2008, Pacific Oncology joined with Oregon Health & Science University and created greater access to…
On May 3, 2008, a major expansion of Oregon State University’s College of Veterinary Medicine’s large animal clinical…
On Feb. 20, 2008, Lori and Jen-Hsun Huang of Los Altos Hills, California, announced a $5 million gift…
On Feb. 19, 2008, Lokey Laboratories which house the Nanoscience Research Center at the University of Oregon (UO)…
On Jan. 23, 2008, the Oregon Health & Science University (OHSU) Basic Science Building was renamed the Richard…
In 2008, the Vaccine & Gene Therapy Institute of Florida VGTI Florida (VGTI-FL) was founded as an independent…
On Jul. 11, 2007, Oregon Health & Science University (OHSU) announced a leadership gift of $5.5 million from…
On May 21, 2007, Oregon Health & Science University (OHSU) announced that Grover Bagby, M.D., after 15 years…
On Mar. 20, 2007, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced a five-year, $24 million…
On Feb. 8, 2007, Oregon Health & Science University (OHSU) and the OHSU Foundation announced the largest outright gift…
In 2007, The Oregon Translational Research and Drug Discovery Institute (OTRADI) at Oregon State University was established by…
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
In 2006, The OHSU Peter O. Kohler Pavilion opened as state-of-the-art patient care facility on Marquam Hill in…
On Jul. 18, 2005, Oregon Health & Science University (OHSU) announced receipt of a five-year, $10 million award…
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated nearly 20 acres of land at the South Willamette…
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
On Jul. 2, 2003, Invitrogen bought Molecular Probes for $325 million in cash. The company became part of…
In Jul. 2003, HB 3613 was passed in the Oregon State Legislature and enacted a mandate for the…
On Oct. 10, 2002, the Oregon Opportunity arrived as Oregon Health & Science University (OHSU) broke ground for…
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…